Meshed Vein Graft Patency Trial - VEST
Launched by CARDIOCHIRURGIA E.H. · May 21, 2013
Trial Information
Current as of May 05, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical Indication for elective Coronary Artery Bypass Grafting with at least one vein graft
- • Coronary artery with critical stenosis (over 70%)
- Exclusion Criteria:
- • -
About Cardiochirurgia E.H.
Cardiochirurgia E.H. is a leading clinical trial sponsor specializing in innovative cardiovascular interventions and surgical techniques. Committed to advancing cardiac care, the organization conducts rigorous clinical research aimed at improving patient outcomes and enhancing the safety and efficacy of cardiovascular treatments. With a team of experienced professionals and a robust network of clinical sites, Cardiochirurgia E.H. fosters collaboration between researchers, healthcare providers, and patients, ensuring the highest standards of ethical conduct and scientific integrity in all its trials. Their dedication to excellence positions them at the forefront of cardiovascular research, contributing significantly to the evolving landscape of cardiac health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rome, , Italy
Turin, , Italy
Patients applied
Trial Officials
Luca Weltert, MD
Principal Investigator
European Hospital - Rome
Ruggero De Paulis, MD
Study Chair
European Hospital - Rome
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials